资讯

FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
Express Healthcare7 小时
FDA approves first blood test to support Alzheimer’s diagnosis
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...
Medical Dialogues1 小时
USFDA clears first blood test used in diagnosing Alzheimer's Disease
The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse ...
InsideHook on MSN15 小时
The FDA Just Approved an Alzheimer's Disease Blood Test
If you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...
MyChesCo on MSN22 小时
Groundbreaking Blood Test Offers New Hope for Alzheimer’s Diagnosis
The U.S. Food and Drug Administration (FDA) has cleared a first-of-its-kind blood test designed to aid in the diagnosis of ...
pharmaphorum14 小时
FDA clears first blood test for Alzheimer's disease
The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward ...
FDA clears 1st blood test to help diagnose Alzheimer's disease
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.